Xilong Scientific Co., Ltd.
002584.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥4,038 | CN¥5,986 | CN¥4,056 | CN¥6,203 |
| - Cash | CN¥593 | CN¥560 | CN¥691 | CN¥770 |
| + Debt | CN¥911 | CN¥1,010 | CN¥1,048 | CN¥695 |
| Enterprise Value | CN¥4,355 | CN¥6,436 | CN¥4,412 | CN¥6,128 |
| Revenue | CN¥7,816 | CN¥7,693 | CN¥6,183 | CN¥6,838 |
| % Growth | 1.6% | 24.4% | -9.6% | – |
| Gross Profit | CN¥536 | CN¥460 | CN¥442 | CN¥557 |
| % Margin | 6.9% | 6% | 7.1% | 8.2% |
| EBITDA | CN¥176 | CN¥153 | CN¥220 | CN¥322 |
| % Margin | 2.3% | 2% | 3.6% | 4.7% |
| Net Income | CN¥62 | CN¥33 | CN¥89 | CN¥187 |
| % Margin | 0.8% | 0.4% | 1.4% | 2.7% |
| EPS Diluted | 0.11 | 0.06 | 0.15 | 0.32 |
| % Growth | 83.3% | -60% | -53.1% | – |
| Operating Cash Flow | CN¥302 | -CN¥285 | -CN¥191 | CN¥347 |
| Capital Expenditures | -CN¥45 | -CN¥215 | -CN¥324 | -CN¥57 |
| Free Cash Flow | CN¥257 | -CN¥500 | -CN¥515 | CN¥290 |